Simple to use, intuitive, and mobile … I love using it in my practice. Paul Karpecki, OD
Irvine, CA (PRWEB) April 23, 2014
A feature-rich FLEX visual acuity app for Ophthalmology, Optometry, clinical trials and other medical uses has just been released on Apple iTunes for Retina display iPad devices as an add-in to Konan Medical’s Chart2020 Duo app. The FLEX visual acuity test allows clinicians to dynamically and instantly adjust visual acuity test parameters to test from 33 cm (14 inches) to 6 meters (20 feet). The test includes industry standard, Sloan specification literate, illiterate, and pediatric optotypes for western and 6 global languages. FLEX is gesture- driven to simply and intuitively display acuity lines, single letters, and full charts including smart randomization and reverse contrast on retina display iPad devices.
The Chart2020 Duo app provides a framework for precise, iPad administered vision tests as well as the most advanced controller for distance visual acuity and ocular performance testing with the Windows application, Chart2020.
“FLEX marks a new chapter in our vision assessment products, bringing professional-grade visual acuity tests onto high resolution mobile devices such as Apple’s Retina display iPads,” said Charles Wm. Stewart, OD, Konan Medical USA CEO. “We have previewed FLEX with Ophthalmologists and Optometrists for standard VA testing, out of office screenings, clinical trials, school nurses, and even with emergency rooms physicians to bring the vision tests to the patients. FLEX is on-the-fly precision acuity testing at reading distances, computer distances or even full distance vision testing,” said Dr. Stewart. “"The new FLEX visual acuity feature in Konan’s Chart2020 Duo app is powerful but simple to assess reading, computer distances, even distance acuities", said Paul Karpecki, OD. “Simple to use, intuitive, and mobile … I love using it in my practice.”
Chart2020 is now used in more than 12 countries in academic, research, clinical trials, and clinical practice settings. Compliant with ISO 8596-2009 standards, the new Chart2020 Version 5 features an industry leading user experience that utilizes self-hiding Smart Docks in which the extensive library of tests and media can easily be added / managed through one-button drag and drop functions.
Konan Medical is making complementary apps available, in quantities limited by Apple’s Terms and Conditions, to academic institutions, Optometry students, Ophthalmology residents, and other qualified settings by contacting sales(at)KonanMedical(dot)com.
Konan’s Chart2020 applications are multi-platform visual acuity and ocular performance testing solutions featuring guided, self-scoring Konan Wizards. An extensive library of industry standard, innovative polarized vision tests, ColorDx® military-grade color vision testing, and video and image media are uniquely controlled using a simple and intuitive user experience from the iPad Chart2020 Duo application, a minimalist Apple TV remote, or standard mouse, keyboard, multi-button remotes. Chart2020 is compliant to ISO standards, is FDA listed and CE marked. Chart2020 is used world-wide in academic, research, and clinical eye care practices. Chart2020 is also available with the ColorDx color vision tests developed by Terrace Waggoner, OD that were recently featured in the Wall Street Journal article New Outlook on Color Blindness.
Headquartered in Irvine, California, Konan Medical USA Inc. develops, manufactures, sells, distributes and services specialty diagnostic products for eye care clinicians and eye banks, and supplies clinical diagnostic products for many of the leading ophthalmic product companies in support of sponsored FDA clinical trials research in the United States and other parts of the world. Konan Medical USA, Inc. is an EN ISO 13485:2012 certified company. For more information on Chart2020 and Konan, visit http://www.KonanMedical.com.